FDA Submits Collection of Information for OMB Review, Requests Comments on Promotional Labeling and Advertising Materials

Summary

The Food and Drug Administration (FDA) has submitted a proposed collection of information to the Office of Management and Budget (OMB) for review and clearance, seeking public comment on the requirements for providing promotional labeling and advertising materials for human prescription drugs in both electronic and non-electronic formats.